Editorial For reprint orders, please contact [removed] EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop? Expert Rev. Clin. Immunol. 9(2), 95–[removed])

First Page		Document Content
Date: 2013-12-11 22:21:47 Immune system Epstein–Barr virus Teplizumab Otelixizumab Tumor necrosis factor-alpha Anti-CD3 monoclonal antibody Immunosuppressive drug Monoclonal antibody therapy Tolerx Monoclonal antibodies Medicine Immunology		Editorial For reprint orders, please contact [removed] EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop? Expert Rev. Clin. Immunol. 9(2), 95–[removed]) Document is deleted from original location. Use the Download Button below to download from the Web Archive. Download Document from Web Archive File Size: 690,48 KB

Document is deleted from original location. Use the Download Button below to download from the Web Archive.